ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
University Hospital of Pisa
Pisa, ItaliaPublicaciones en colaboración con investigadores/as de University Hospital of Pisa (1)
2019
-
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
The Lancet Oncology, Vol. 20, Núm. 6, pp. 849-861